Oxy Burn

Formula Purposes & Benefits

Oxy Burn is designed to support fat burning during exercise, maintain healthy cholesterol levels, manage inflammation, and boost immune health. Our formula leverages a blend of herbs, amino acids, vitamins, and superfoods in potent combinations to provide a world-class supplement. Each ingredient is included at evidence-based dosages to enhance weight loss, exercise performance, and overall health.

Benefits of Each Ingredient

Raspberry Ketone

• Decreases anxiety and supports positive mood.
• Enhances sleep cycles by improving natural melatonin production.
• Supports gut-brain axis through increased serotonin production in gut neurons.

Caffeine

• Optimizes energy levels, cognitive function, and mental alertness.
• Enhances exercise performance when taken as a supplement.

L-Carnitine

• Improves exercise performance and increases nutrient delivery to muscles.
• Acts as a buffer for muscle acidity, reducing exercise-induced fatigue.

ECGC

• Supports antioxidant and cognitive functions.
• Enhances muscle mass and endurance performance.
• Combats inflammation and stabilizes blood pressure.

Yohimbine Bark

• May increase energy, sexual function, and metabolism.

Kola Nut

• May support increased fat burning and energy levels.

Proper Use of This Supplement

As a dietary supplement, take one (1) capsule in the morning. Do not exceed two (2) capsules in a 24-hour period and avoid taking it past 4 PM. Use for no longer than eight weeks consecutively, followed by a break of at least two weeks before resuming use.

Why Choose Oxy Burn Over Other Formulas?

Quality Assurance

• Made in the USA, GMP certified, and produced in an FDA-registered facility using third-party independently tested ingredients.

Effective Dosages

• Utilizes quality, evidence-based thermogenic aids without low dosages or fillers.

Pure Ingredients

• Contains high-quality thermogenic agents in a scientifically backed formula, avoiding cheap or toxic non-evidence-based ingredients.

---

Sources

1. Sureda, A., & Pons, A. (2012). Arginine and citrulline supplementation in sports and exercise: ergogenic nutrients?. Medicine and sport science, 59, 18–28. DOI:10.1159/000341937
2. Szefel, J., Danielak, A., & Kruszewski, W. J. (2019). Metabolic pathways of L-arginine and therapeutic consequences in tumors. Advances in medical sciences, 64(1), 104–110. DOI:10.1016/j.advms.2018.08.018
3. Rodrigues-Krause, J., et al. (2018). Association of l-Arginine Supplementation with Markers of Endothelial Function in Patients with Cardiovascular or Metabolic Disorders. Nutrients, 11(1), 15. DOI:10.3390/nu11010015
4. Hu, S., et al. (2017). L-Arginine Modulates Glucose and Lipid Metabolism in Obesity and Diabetes. Current protein & peptide science, 18(6), 599–608. DOI:10.2174/1389203717666160627074017
5. Sugino, T., et al. (2008). L-ornithine supplementation attenuates physical fatigue in healthy volunteers by modulating lipid and amino acid metabolism. Nutrition research, 28(11), 738–743. DOI:10.1016/j.nutres.2008.08.008
6. Sivashanmugam, M., et al. (2017). Ornithine and its role in metabolic diseases: An appraisal. Biomedicine & pharmacotherapy, 86, 185–194. DOI:10.1016/j.biopha.2016.12.024
7. Ngondi, J. L., et al. (2009). IGOB131, a novel seed extract of the West African plant Irvingia gabonensis, significantly reduces body weight and improves metabolic parameters in overweight humans. Lipids in health and disease, 8, 7. DOI:10.1186/1476-511X-8-7
8. Ferreira, G. C., & McKenna, M. C. (2017). L-Carnitine and Acetyl-L-carnitine Roles and Neuroprotection in Developing Brain. Neurochemical research, 42(6), 1661–1675. DOI:10.1007/s11064-017-2288-7
9. Gasperi, V., et al. (2019). Niacin in the Central Nervous System: An Update of Biological Aspects and Clinical Applications. International journal of molecular sciences, 20(4), 974. DOI:10.3390/ijms20040974
10. Gentilcore D. (2016). Louis Sambon and the Clash of Pellagra Etiologies in Italy and the United States, 1905-14. Journal of the history of medicine and allied sciences, 71(1), 19–42. DOI:10.1093/jhmas/jrv002
11. Kirkland J. B. (2009). Niacin status and treatment-related leukemogenesis. Molecular cancer therapeutics, 8(4), 725–732. DOI:10.1158/1535-7163.MCT-09-0042
12. Hoskin, P., et al. (2009). Accelerated radiotherapy, carbogen, and nicotinamide (ARCON) in the treatment of advanced bladder cancer. International journal of radiation oncology, biology, physics, 73(5), 1425–1431. DOI:10.1016/j.ijrobp.2008.06.1950
13. Dording, C. M., et al. (2015). A double-blind placebo-controlled trial of maca root as treatment for antidepressant-induced sexual dysfunction in women. Evidence-based complementary and alternative medicine, 2015, 949036. DOI:10.1155/2015/949036
14. Pu, W. L., et al. (2020). Anti-inflammatory effects of Rhodiola rosea L.: A review. Biomedicine & pharmacotherapy, 121, 109552. DOI:10.1016/j.biopha.2019.109552
15. Trexler, E. T., et al. (2015). International society of sports nutrition position stand: Beta-Alanine. Journal of the International Society of Sports Nutrition, 12, 30. DOI:10.1186/s12970-015-0090-y
16. Auyeung, K. K., et al. (2016). Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal Cancers. The American journal of Chinese medicine, 44(1), 1–22. [DOI:10.1142/S0192415X16500014](https://doi.org/10.1142/S0192415X165
17. Auyeung, K. K., Han, Q. B., & Ko, J. K. (2016). Astragalus membranaceus: A Review of its Protection Against Inflammation and Gastrointestinal Cancers. The American journal of Chinese medicine, 44(1), 1–22. DOI:10.1142/S0192415X16500014
18. Zhang, Z., Zhang, L., & Xu, H. (2019). Effect of Astragalus polysaccharide in treatment of diabetes mellitus: a narrative review. Journal of traditional Chinese medicine, 39(1), 133–138.
19. Cruzat, V., et al. (2018). Glutamine: Metabolism and Immune Function, Supplementation and Clinical Translation. Nutrients, 10(11), 1564. DOI:10.3390/nu10111564
20. Salinas-Casado, J., et al. (2020). Review of the experience and evidence of Pygeum africanum in urological practice. Actas urologicas espanolas, 44(1), 9–13. DOI:10.1016/j.acuro.2019.08.002